Cargando…
Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
Autores principales: | Hall, Peter, McCabe, Christopher, Hulme, Claire, Edlin, Richard, Dunn, Janet, Cameron, David, Stein, Rob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980319/ http://dx.doi.org/10.1186/1745-6215-14-S1-O5 |
Ejemplares similares
-
The use of early decision modelling and value of information analysis in an adaptive trial design: results from the OPTIMA preliminary study
por: Hall, Peter, et al.
Publicado: (2015) -
Using adaptive designs for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests
por: Dunn, Janet, et al.
Publicado: (2013) -
An adaptive biomarker strategy clinical trial design
por: Wason, James, et al.
Publicado: (2013) -
Can CMR be the new ‘gold standard’ for constrictive pericarditis?
por: Power, John A, et al.
Publicado: (2012) -
New "gold standard" for assessing myocardial oedema in STEMI?
por: McAlindon, Elisa, et al.
Publicado: (2013)